The Journal of Pediatrics
Volume 149, Issue 3 , Pages 336-341.e1 , September 2006

A multicenter prospective randomized trial of corticosteroids in primary therapy for Kawasaki disease: Clinical course and coronary artery outcome

Received 24 September 2005 ,Revised 2 May 2006 ,Accepted 16 May 2006.

References 

  1. Kawasaki T , Kosaki F , Okawa S , Shigematsu I , Yanagawa H . A new infantile acute febrile mucocutaneous lymph node syndrome (MCLS) prevailing in Japan . Pediatrics . 1974;54:271–276
  2. Yanagawa H , Nakamura Y , Yashiro M . The results of 15th nationwide survey of Kawasaki disease in Japan . J Pediatr Practice . 2000;63:121–132 (in Japanese)
  3. Furusho K , Kamiya T , Nakano H , Kiyosawa N , Shinomiya K , Hayashidera T , et al.   High-dose intravenous gammaglobulin for Kawasaki disease . Lancet . 1984;2:1055–1058
  4. Newburger JW , Takahashi M , Beiser AS , Burns JC , Bastian J , Chung KJ , et al.   Single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome . N Engl J Med . 1991;324:1633–1639
  5. Newburger JW , Takahashi M , Burns JC , Beiser AS , Chung KJ , Duffy CE , et al.   Treatment of Kawasaki syndrome with intravenous gamma globulin . N Engl J Med . 1986;315:341–347
  6. Wallace CA , French JW , Kahn SJ , Sherry DD . Initial intravenous gamma globulin treatment failure in Kawasaki disease . Pediatrics . 2000;105:e78
  7. Burns JC , Capparelli EV , Brown JA , Newburger JW , Glode MP . Intravenous gamma-globulin treatment and retreatment in Kawasaki disease . Pediatr Infect Dis J . 1998;17:1144–1148
  8. Han RK , Silverman ED , Newman A , McCrindle BW . Management and outcome of persistent or recurrent fever after initial intravenous gamma globulin therapy in acute Kawasaki disease . Arch Pediatr Adolesc Med . 2000;154:694–699
  9. Durongpisitkul K , Soongswang J , Laohaprasitiporn D , Nana A , Prachuabmoh C , Kangkagate C . Immunoglobulin failure and retreatment in Kawasaki disease . Pediatr Cardiol . 2003;24:145–148
  10. Durongpisitkul K , Gururaj VJ , Paark JM , Martin CF . The prevention of coronary artery aneurysm in Kawasaki disease (a meta-analysis on the efficacy of aspirin and immunoglobulin treatment) . Pediatrics . 1995;96:1057–1061
  11. Zaitsu M , Hamasaki Y , Tashiro K , Matsuo M , Ichimaru T , Fujita I , et al.   Ulinastatin, an elastase inhibitor, inhibits the increased mRNA expression of prostaglandin H2 synthase-type 2 in Kawasaki disease . J Infect Dis . 2000;181:1101–1109
  12. Weiss JE , Eberhard BA , Chowdhury D , Gottlieb BS . Infliximab as a novel therapy for refractory Kawasaki disease . J Rheumatol . 2004;31:808–810
  13. Shinohara M , Sone K , Tomomasa T , Morikawa A . Corticosteroids in the treatment of the acute phase of Kawasaki disease . J Pediatr . 1999;135:411–413
  14. Jibiki T , Terai M , Kurosaki T , Nakajima H , Suzuki K , Inomata H , et al.   Efficacy of intravenous immune globulin therapy combined with dexamethasone for the initial treatment of acute Kawasaki disease . Eur J Pediatr . 2004;163:229–233
  15. Sundel RP , Baker AL , Fulton DR , Newberger JW . Corticosteroids in the initial treatment of Kawasaki disease (report of a randomized trial) . J Pediatr . 2003;142:611–616
  16. Kato H , Koike S , Yokoyama T . Kawasaki disease (effect of treatment on coronary artery involvement) . Pediatrics . 1979;63:175–179
  17. Shulman ST , Rowley AH . Advances in Kawasaki disease . Eur J Pediatr . 2004;163:285–291
  18. Dale RC , Saleem MA , Daw S , Dillon MJ . Treatment of severe complicated Kawasaki disease with oral prednisolone and aspirin . J Pediatr . 2000;137:723–726
  19. Harada K . Intravenous gamma-globulin treatment in Kawasaki disease . Acta Paediatr Jpn . 1991;33:805–810
  20. Yanagawa H , Yashiro M , Nakamura Y , Kawasaki T , Kato H . Epidemiologic pictures of Kawasaki disease in Japan from the nationwide incidence survey in 1991 and 1992 . Pediatrics . 1995;95:475–479
  21. Research Committee on Kawasaki Disease . Report of the Subcommittee on Standardization of Diagnostic Criteria and Reporting of Coronary Artery Lesions in Kawasaki Disease. . Tokyo: Ministry of Health and Welfare; 1984;
  22. Behrman RE , Kliegman RM , Arvin HM . Nelson textbook of pediatrics . 15th ed. Philadelphia: WB Saunders; 1996;
  23. Lin CY , Lin CC , Hwang B , Chiang BN . Cytokines predict coronary aneurysm formation in Kawasaki disease patients . Eur J Pediatr . 1993;152:309–312
  24. Matsubara T , Furukawa S , Yabuta K . Serum levels of tumor necrosis factor, interleukin-2 receptor, and interferon-gamma in Kawasaki disease involved coronary artery lesions . Clin Immunol Immunopathol . 1990;56:29–36
  25. Lin CY , Lin CC , Hwang B , Chiang BN . The changes of interleukin-2, tumour necrotic factor and gamma-interferon production among patients with Kawasaki disease . Eur J Pediatr . 1991;150:179–182
  26. Lin CY , Lin CC , Hwang B , Chiang B . Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki disease . J Pediatr . 1992;121:924–926
  27. Okada Y , Shinohara M , Kobayashi T , Inoue Y , Tomomasa T , Kobayashi T , et al.   Effect of corticosteroids in addition to intravenous gamma globulin therapy on serum cytokine levels in the acute phase of Kawasaki disease in children . J Pediatr . 2003;143:363–367
  28. Streck WF , Lockwood DH . Pituitary recovery following short-term suppression with corticosteroids . Am J Med . 1979;66:910–914
  29. Wilmsmeyer W , Ukena D , Wagner TO , Sybrecht GW . First-time treatment with steroids in bronchial asthma (comparison of the effects of inhaled beclomethasone and of oral prednisone on airway function, bronchial reactivity and hypothalamic-pituitary-adrenal axis) . Eur Respir J . 1990;3:786–791
  30. Galon J , Franchimont D , Hiroi N , Frey G , Boettner A , Ehrhart-Bornstein M , et al.   Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells . FASEB J . 2002;16:61–71
  31. Hsieh KS , Weng KP , Lin CC , Huang TC , Lee CL , Huang SM . Treatment of acute Kawasaki disease (aspirin’s role in the febrile stage revisited) . Pediatrics . 2004;114:e689–e693

PII: S0022-3476(06)00463-X

doi: 10.1016/j.jpeds.2006.05.025

The Journal of Pediatrics
Volume 149, Issue 3 , Pages 336-341.e1 , September 2006

Article Tools

* Image Usage & Resolution